lamivudine has been researched along with transforming growth factor beta in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Kadasi, H; Flisiak, I; Flisiak, R; Jaroszewicz, J; Prokopowicz, D | 1 |
1 trial(s) available for lamivudine and transforming growth factor beta
| Article | Year |
|---|---|
Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Matrix Metalloproteinase 1; Middle Aged; Reverse Transcriptase Inhibitors; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |